Apaf-1 Is a Mediator of E2F-1-induced Apoptosis
2002 · Journal of Biological Chemistry · 136 citations
https://doi.org/10.1074/jbc.m200805200
N
Noriko Nishimura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
257
Papers
3.9K
Citations
33
h-index
80
i10-index
Noriko Nishimura is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Multiple Myeloma Research and Treatments & Trace Elements in Health. The author has an h-index of 33, co-authored 219 publications.
ORCID: 0000-0001-8720-6930Papers by this author
worksComparison of infectious complications with BCMA-directed therapies in multiple myeloma
2024 · Blood Cancer Journal · 32 citations
https://doi.org/10.1038/s41408-024-01043-5
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
2024 · Blood Cancer Journal · 26 citations
https://doi.org/10.1038/s41408-024-01048-0
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan
2017 · Supportive Care in Cancer · 15 citations
https://doi.org/10.1007/s00520-017-3747-z
R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma
2012 · Experimental Hematology and Oncology · 12 citations
https://doi.org/10.1186/2162-3619-1-30
Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy
2023 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-023-40026-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat